NRC - National Research Corporation
NEXT EARNINGS:
Apr 27, 2026
Price:
--
--
Market Cap:
393.97M
Volume:
41,965
Avg Volume:
106,255
52 Week Range:
9.755-22.79
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Beta:
0.58
Last Dividend:
$0.52
Exchange:
NASDAQ
Country:
US
Employees:
368
IPO Date:
2013-05-23
EPS (TTM):
0.52
P/E Ratio:
36.22
Revenue (TTM):
137.39M
Total Assets:
134.88M
Total Debt:
79.03M
Cash & Equiv:
4.14M
Rev Growth (5Y):
0.6%
EPS Growth (5Y):
-18.9%
FCF Growth (5Y):
-15.6%
ROCE:
23.0%
Debt/Equity:
5.65
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-03 | $0.16 | — | — | $35.2M | — | — |
| 2025-10-27 | $0.23 | — | — | $34.6M | — | — |
| 2025-07-28 | $0.28 | — | — | $34.0M | — | — |
| 2025-04-28 | $0.25 | — | — | $33.6M | — | — |
| 2025-02-11 | $0.36 | — | — | $36.9M | — | — |
| 2025-01-27 | $0.28 | — | — | $36.9M | — | — |
| 2024-10-25 | $0.24 | — | — | $35.8M | — | — |
| 2024-08-06 | $0.26 | — | — | $35.0M | — | — |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 137.39M | 143.06M | 148.58M | 151.57M | 147.95M | 133.28M | 127.98M | 119.69M | 117.56M | 109.38M | 102.34M | 98.84M |
| Net Income | 11.60M | 24.78M | 30.97M | 31.80M | 37.47M | 37.26M | 32.41M | 30.05M | 22.94M | 20.52M | 17.61M | 18.16M |
| EPS | 0.52 | 1.05 | 1.26 | 1.28 | 1.47 | 1.48 | 1.30 | 1.11 | 0.54 | 0.49 | 0.42 | 0.44 |
| Total Assets | 134.88M | 132.54M | 122.44M | 130.46M | 157.54M | 133.42M | 110.69M | 107.68M | 127.32M | 120.62M | 129.10M | 129.51M |
| Total Debt | 79.03M | 64.41M | 38.96M | 23.39M | 28.68M | 33.24M | 36.62M | 3.67M | 1.07M | 2.68M | 2.40M | 2.33M |
| Cash & Equivalents | 4.14M | 4.23M | 6.65M | 25.03M | 54.36M | 34.69M | 13.52M | 12.99M | 34.73M | 33.02M | 42.15M | 40.04M |
| Operating Cash Flow | 26.45M | 34.62M | 38.11M | 36.27M | 46.34M | 40.64M | 40.92M | 39.85M | 28.09M | 26.84M | 21.89M | 26.20M |
| Free Cash Flow | 15.74M | 19.18M | 22.33M | 26.43M | 40.83M | 36.65M | 36.26M | 33.88M | 23.27M | 22.87M | 18.95M | 23.70M |
| FCF per Share | 0.70 | 0.81 | 0.91 | 1.06 | 1.61 | 1.46 | 1.46 | 1.25 | 0.96 | 0.94 | 0.78 | 0.98 |
| Book Value | 13.99M | 31.28M | 48.95M | 72.03M | 85.34M | 64.31M | 32.89M | 19.08M | 90.04M | 82.81M | 74.22M | 87.75M |
| Cash & ST Investments | 4.14M | 4.23M | 6.65M | 25.03M | 54.36M | 34.69M | 13.52M | 12.99M | 34.73M | 33.02M | 42.15M | 40.04M |
| ROC Equity | 0.83 | 0.79 | 0.63 | 0.44 | 0.44 | 0.58 | 0.99 | 1.57 | 0.25 | 0.25 | 0.24 | 0.21 |